Hypertension (HTN) is a common condition observed in primary care. The disease
is associated with morbidity, mortality, and cost. The purpose of this article is to
present the latest treatment and management of HTN with emphasis on the newly
published Eighth Joint National Committee (JNC 8) treatment guidelines. The
new JNC 8 guidelines reflect pharmacologic treatment of HTN in adults 18 years
and older. The new guidelines are limited to the treatment of HTN in the general
population and those with diabetes mellitus or chronic kidney disease.
Keywords: Eighth Joint National Committee guidelines, hypertension,
pharmacologic treatment